Remitogen Uses, Dosage, Side Effects and more
Remitogen is a humanized monoclonal antibody that is being studied as a treatment for hematologic cancers.
| Trade Name | Remitogen |
| Generic | Apolizumab |
| Apolizumab Other Names | Apolizumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in lymphoma (non-hodgkin's), leukemia (lymphoid), and solid tumors.
How Remitogen works
Remitogen is a humanized monoclonal antibody directed against 1D10, a polymorphic determinant on the HLA-DR beta chain that is expressed on normal and neoplastic B cells. Remitogen induces complement-mediated cytotoxicity, antibody-dependent cell-mediated cytotoxicity, and apoptosis of 1D10 antigen-positive B cells in vitro.
